tiprankstipranks
Advertisement
Advertisement

AXGN Stock Latest News

AxoGen Earnings Call Highlights Strong Growth, Margin Strain
Company AnnouncementsAxoGen Earnings Call Highlights Strong Growth, Margin Strain
14d ago
AXGN
AxoGen price target raised to $55 from $50 at Jefferies
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Jefferies
26d ago
AXGN
AxoGen price target raised to $55 from $50 at Canaccord
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Canaccord
27d ago
AXGN
AxoGen price target raised to $53 from $50 at H.C. Wainwright
PremiumThe Fly
AxoGen price target raised to $53 from $50 at H.C. Wainwright
27d ago
AXGN
AxoGen price target raised to $55 from $50 at Citizens
PremiumThe Fly
AxoGen price target raised to $55 from $50 at Citizens
27d ago
AXGN
AxoGen price target raised to $55 from $50 at Jefferies
PremiumThe FlyAxoGen price target raised to $55 from $50 at Jefferies
27d ago
AXGN
AxoGen reports Q2 adjusted EPS 12c, consensus 12c
Premium
The Fly
AxoGen reports Q2 adjusted EPS 12c, consensus 12c
28d ago
AXGN
AxoGen raises FY26 revenue view to $279M from $270M, consensus $270.92M
Premium
The Fly
AxoGen raises FY26 revenue view to $279M from $270M, consensus $270.92M
28d ago
AXGN
AxoGen boosts outlook after strong second-quarter growth
PremiumCompany Announcements
AxoGen boosts outlook after strong second-quarter growth
28d ago
8K
AXGN
Trace Biosciences announces strategic investment from Axogen
PremiumThe Fly
Trace Biosciences announces strategic investment from Axogen
28d ago
AXGN
Is AXGN a Buy, Before Earnings?
PremiumPre-Earnings
Is AXGN a Buy, Before Earnings?
30d ago
AXGN
Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down
PremiumThe Fly
Neuronetics appoints Nir Naor as CFO, CLO Andrew Macan to step down
1M ago
AXGN
STIM
AxoGen Shareholders Approve Directors, Auditor and Executive Pay
PremiumCompany AnnouncementsAxoGen Shareholders Approve Directors, Auditor and Executive Pay
2M ago
8K
AXGN
AxoGen’s New Head-to-Head Nerve Repair Study Puts Avance Graft Under the Spotlight
Premium
Company Announcements
AxoGen’s New Head-to-Head Nerve Repair Study Puts Avance Graft Under the Spotlight
2M ago
AXGN
AxoGen price target raised to $48 from $41 at Raymond James
Premium
The Fly
AxoGen price target raised to $48 from $41 at Raymond James
4M ago
AXGN
AxoGen price target raised to $50 from $45 at Canaccord
PremiumThe Fly
AxoGen price target raised to $50 from $45 at Canaccord
4M ago
AXGN
AxoGen price target raised to $50 from $39 at H.C. Wainwright
PremiumThe Fly
AxoGen price target raised to $50 from $39 at H.C. Wainwright
4M ago
AXGN
AxoGen price target raised to $50 from $42 at Citizens
PremiumThe Fly
AxoGen price target raised to $50 from $42 at Citizens
4M ago
AXGN
AxoGen rises 12.8%
PremiumThe Fly
AxoGen rises 12.8%
4M ago
AXGN
AxoGen raises FY26 revenue view to $270M from $265.7M, consensus $265.89M
PremiumThe FlyAxoGen raises FY26 revenue view to $270M from $265.7M, consensus $265.89M
4M ago
AXGN
AxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook
Premium
Company Announcements
AxoGen Delivers Strong Q1 Growth and Raises 2026 Outlook
4M ago
8K
AXGN
AxoGen reports Q1 adjusted EPS 7c, consensus 7c
Premium
The Fly
AxoGen reports Q1 adjusted EPS 7c, consensus 7c
4M ago
AXGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >